DAPHNE D'AMATO

University of Turin

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (12)

Elisabetta Bugianesi

University of Turin

ITALY

View details

Gian Paolo Caviglia

Assistant Professor

Università degli Studi di Torino

ITALY

View details

Heather Cordell

Professor of Statistical Genetics

Newcastle University

UNITED KINGDOM

View details

Alessio Gerussi

Lecturer

University of Milano-Bicocca

ITALY

View details

Fabio Marra

ITALY

View details

PIETRO ANDREONE

Professor of Medicine and Surgery

Università degli Studi di Roma Tor Vergata Facoltà di Medicina e Chirurgia

ITALY

View details

Shintaro Yagi

Professor

Kanazawa University

JAPAN

View details

Guido CARPINO

Università degli Studi di Roma La Sapienza

ITALY

View details

Mark Aldersley

Consultant Hepatologist and Honorary Senior Lecturer in Medicine

Leeds Teaching Hospitals NHS Trust

UNITED KINGDOM

View details

Andrea Galli

Full Professor Of Gastroenterology

University of Arkansas - Rome Center

ITALY

View details

Giovanni Galati

Campus Bio Medico University Hospital

ITALY

View details

Giorgio Maria Saracco

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

DAPHNE D'AMATO

Research Interests

Explore related searches

Contact this professor

Articles (10)

Prognostic Value of Simple Non-Invasive Tests for the Risk Stratification of Incident Hepatocellular Carcinoma in Cirrhotic Individuals with Non-Alcoholic Fatty Liver Disease

Cross-Sectional and Longitudinal Performance of Non-Invasive Tests of Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease

A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis

Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055))

Role of ductular reaction and ductular–canalicular junctions in identifying severe primary biliary cholangitis

Quantitative data do not coincide with meaningful insights: Reply to Shahreedhan et al.

Predictors of serious adverse events and non‐response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid

Expression of SARS-Cov-2 Entry Factors in Patients with Chronic Hepatitis

Autoimmune hepatitis or drug-induced autoimmune hepatitis following Covid-19 vaccination?

Crosstalk between Irisin Levels, Liver Fibrogenesis and Liver Damage in Non-Obese, Non-Diabetic Individuals with Non-Alcoholic Fatty Liver Disease.

Collaborators (12)

Elisabetta Bugianesi

Gian Paolo Caviglia

Heather Cordell

Alessio Gerussi

Fabio Marra

PIETRO ANDREONE

Shintaro Yagi

Guido CARPINO

Mark Aldersley

Andrea Galli

Giovanni Galati

Giorgio Maria Saracco

Make your next move.